Affordability and Innovation – the Key Factors of Our Growth
As our vision statement clearly indicates, Agappe is focused to establish globally as a premier in-vitro diagnostic corporate and to be the best partner in the diagnostic field for the welfare of mankind.
As a matter of fact, we believe in providing high quality diagnostic solutions to our customers, through highest level of customer connect by ensuring innovative and affordable products for an everlasting relationship.
Basically, awareness of the importance of prevention is better than cure has gathered greater momentum in the Indian society at large in recent years. Prevention techniques are well established worldwide, but the awareness of one’s present health status and assessment of available indicators for one’s future probable complications contribute to the greater penetration and significance to IVD Industry. As per statistics, more than 10 percent of healthcare expenditure is on diagnostic tools than treatment.
With the advancement of science, our society does resort to earlier diagnostic tools rather than treatment. However, majority of diagnostic analyzers and reagents are imported to India and hence diagnosis cost is substantially higher than affordable to common man. To reinforce our vision welfare of mankind and ensuring the reachability of diagnostic solutions to the rural population of India, Agappe has spared no efforts to market many essential diagnostic testing at affordable price. Agappe is surely pioneering in bringing the products, which are within reach to every needy individuals. Agappe’s innovation on analyzers and reagents is aimed at offering the much-needed competitive edge to clinical laboratory tests by offering precise and trustworthy results, so as to make diagnostic tools available at pocket friendly price across India and the world over, literally fulfilling our vision statement.
Importance of Automation in Pre-analytics
Advancement in the development of electronics, imaging, information technology, microfluidics, and robotics are the key for the new trends in the IVD industry. In today’s world, the modern laboratories are equipped with the latest analytical automated analyzers to give the best result to the clients. Since most these analyzers are controlled by dedicated software, it is easy for the technologist to operate these instruments and to understand the analytical errors if any.
It is estimated that 70 percent of the error in the clinical diagnosis is due to pre-analytical variables. This is mainly due to human errors that can occur when the blood sample is taken, transferred to the test tube and labelled.
In line with providing effective solutions in pre-analytical segment, Agappe’s R&D team has taken a step forward and has developed Mispa Label – the Tube Labelling System. The system is having 6 channels with capability of connecting with hospital information system/laboratory information system. The system is developed with minimal robotics and very low recurring cost to support productivity and efficiency in the laboratories. Mispa Label will reduce the pre-analytical variation thus assuring error free testing.
To back up the pre-analytical, our R&D team is also engaged in the development of the Vein Detector in association with the licensed technology from Sree Chitra Tirunal Institute for Medical Sciences and Technology – Trivandrum, one of the renowned institutions of India.
